Halkova Z, Zaykov C, Antov G, Mihaylova A, Mircheva V, Dinoeva S, Chipilska L
Department of Industrial Toxicology, National Center of Hygiene and Medical Ecology, Sofia, Bulgaria.
Pol J Occup Med Environ Health. 1993;6(1):19-25.
The purpose of this study is to give the toxicological characteristics of subacute oral, dermal and inhalation exposure of microbial preparation Bulmoscide, which is based on bacterium Bacillus thuringiensis, serotype H-14. The study was performed on sexually mature Wistar rats of both sexes. No significant changes in non-specific, clinico-laboratory and biochemical parameters as well as morphological examinations in any tested groups compared to the control groups were revealed. The doses 110 mg.kg-1 (1.32 x 10(9) sp.kg-1) at oral administration in duration of 90 days, 3000 mg.kg-1 (3.6 x 10(10) sp.kg-1) in 21 day dermal application and maximum attainable concentration of dust aerosol 18 mg.kg-3 (2.2 x 10(8) sp.m-3) during a 30 day inhalation exposure are "no toxic effect" levels. On the basis of the data, the selective bacterial insecticide Bulmoscide has been determined to be of low toxic and low hazardous preparation in compliance with the Hygiene Classification of pesticides.
本研究的目的是给出基于苏云金芽孢杆菌H-14血清型的微生物制剂布尔莫西得经口、经皮和吸入亚急性暴露的毒理学特征。研究在性成熟的雌雄Wistar大鼠身上进行。与对照组相比,任何受试组在非特异性、临床实验室和生化参数以及形态学检查方面均未发现显著变化。经口给药90天,剂量为110 mg.kg-1(1.32 x 10(9) 个孢子.kg-1);经皮给药21天,剂量为3000 mg.kg-1(3.6 x 10(10) 个孢子.kg-1);吸入暴露30天,粉尘气溶胶最大可达到浓度为18 mg.kg-3(2.2 x 10(8) 个孢子.m-3),这些均为“无毒性作用”水平。基于这些数据,已确定选择性细菌杀虫剂布尔莫西得符合农药卫生分类,属于低毒、低危害制剂。